Tuesday, 12 Nov 2019

You are here

Achieving Clinical Goals With RINVOQ™ (upadacitinib)

Sponsored by AbbVie

Dr. Alvin Wells highlights data from the SELECT clinical program and discusses treatment goals in RA.

Content developed by AbbVie Inc. This content is intended for US/PR Healthcare Professionals. The US Medical Affairs department of AbbVie Inc. is the copyright owner of this presentation and has paid RheumNow to host this content. AbbVie is solely responsible for all written and oral content within this presentation © [2019] AbbVie Inc. All rights reserved. The speaker has received compensation from the US Medical Affairs department of AbbVie Inc. to prepare and present this information and is speaking on behalf of AbbVie.